These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7443475)

  • 1. [Familial hypercholesterolemic xanthomatosis: effect of colestipol on the lipoprotein profile].
    Drouin P; Sauvanet JP; Demange J; Lambert L; Debry G
    Nouv Presse Med; 1980 Nov; 9(42):3186. PubMed ID: 7443475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
    Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
    Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
    [No Abstract]   [Full Text] [Related]  

  • 3. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
    Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
    Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
    Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
    Kusić M; Gavrilović M; Mihajlović M; Bosković B
    Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride.
    Witztum JL; Jacobs LS; Schonfeld G
    J Clin Endocrinol Metab; 1978 May; 46(5):838-40. PubMed ID: 262768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
    Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
    Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
    Kuo PT; Kostis JB; Moreyra AE; Hayes JA
    Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
    Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
    Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
    Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
    Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid.
    Kuo PT; Toole JF; Schaaf JA; Jones A; Wilson AC; Kostis JB; Moreyra AE
    Stroke; 1987; 18(4):716-21. PubMed ID: 3299882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
    Sundberg EE; Illingworth DR
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 25-hydroxy-vitamin D in familial hypercholesterolemic children receiving colestipol resin.
    Tsang RC; Roginsky MS; Mellies MJ; Glueck CJ
    Pediatr Res; 1978 Oct; 12(10):980-2. PubMed ID: 724301
    [No Abstract]   [Full Text] [Related]  

  • 17. Colestipol tablets in adolescents with familial hypercholesterolaemia.
    Tonstad S; Ose L
    Acta Paediatr; 1996 Sep; 85(9):1080-2. PubMed ID: 8888922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of coronary atherosclerosis in man.
    Myant NB
    Adv Exp Med Biol; 1984; 168():139-52. PubMed ID: 6375296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adrenocortical functions in hypercholesterolemic patients; effect of long-term treatment with colestipol-HCl (author's transl)].
    Morimoto Y
    Horumon To Rinsho; 1981 Feb; 29(2):237-43. PubMed ID: 7261445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
    Düntsch G
    Fortschr Med; 1981 Jan; 99(3):73-5. PubMed ID: 6781999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.